Botulinum toxin (BTX) or Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.
The Hyaluronic Acid segment is anticipated to witness a high CAGR of 8.5% from 2017-2027, which companies would do well to take note of while devising their Hyaluronic Acid Dermal Fillers and Botulinum Toxin Market strategies.

The global Dermal Fillers and Botulinum Toxin market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Dermal Fillers and Botulinum Toxin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dermal Fillers and Botulinum Toxin market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Dermal Fillers and Botulinum Toxin in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Dermal Fillers and Botulinum Toxin manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Allergan
Galderma
Merz
Anika
Suneva
Speciality
HUGEL
Grex

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Hyaluronic Acid Based Fillers
Non-Hyaluronic Acid Based Fillers
Botulinum Toxin

Segment by Application
Aesthetic Volume Restoration
Wrinkle Reduction